Newsletter

Theo Brandt-Sarif, MD

Clinical Trials Expert

  • Specialty is accelerating enrollment into phase 3 clinical trials, with a frequent focus on “rescue” assignments – turning around trials that have gone “off track”
  • Frequently functions as medical monitor, most recently for phase 2 and 3 HCV trials with Sovaldi and Harvoni
  • On occasion has worked on writing assignments, NDA development, and preparation for FDA advisory committee
  • Has extensive experience working in medical affairs/supporting marketing and sales, including development of training programs and several new product launches
  • Clients have included large pharmaceutical corporations such as Gilead, Pfizer, Hoffman La Roche, Schering Plough and Merck; medium-sized companies such as Allergan, Boehringer-Ingelheim and Medimmune; and small companies such as Chiron, MPEX and Intermune
  • Therapeutic areas covered have included HCV, HBV, HIV, infectious disease, fungal disease, vaccines, oncology, cardiovascular, respiratory

Education

  • MBA in Health Care Management: The Wharton School of Business
  • MD: University of the Witwatersrand in Johannesburg
  • Specialty is accelerating enrollment into phase 3 clinical trials, with a frequent focus on “rescue” assignments – turning around trials that have gone “off track”
  • Frequently functions as medical monitor, most recently for phase 2 and 3 HCV trials with Sovaldi and Harvoni
  • On occasion has worked on writing assignments, NDA development, and preparation for FDA advisory committee
  • Has extensive experience working in medical affairs/supporting marketing and sales, including development of training programs and several new product launches
  • Clients have included large pharmaceutical corporations such as Gilead, Pfizer, Hoffman La Roche, Schering Plough and Merck; medium-sized companies such as Allergan, Boehringer-Ingelheim and Medimmune; and small companies such as Chiron, MPEX and Intermune
  • Therapeutic areas covered have included HCV, HBV, HIV, infectious disease, fungal disease, vaccines, oncology, cardiovascular, respiratory

Education

  • MBA in Health Care Management: The Wharton School of Business
  • MD: University of the Witwatersrand in Johannesburg
Close Icon

Theo Brandt-Sarif, MD

Send this to a friend